|
Myelodysplastic syndromes should been renamed as myelodysplastic neoplasms.
|
Jan 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Good riddance to the term "refractory anemia" in myelodysplastic syndromes
|
Oct 2016
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.
|
Jun 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes
|
Aug 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis
|
Feb 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative
|
Jan 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Question prompt list responds to information needs of myelodysplastic syndromes patients and caregivers
|
Jun 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)
|
Nov 2016
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Relationship between lenalidomide dose modification, duration of therapy, and long-term outcomes in patients with myelodysplastic syndromes
|
Oct 2017
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
microRNAs in myelodysplastic syndromes: How much do we know and not know?
|
Mar 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
